Post-discharge pharmacotherapy in people with atrial fibrillation hospitalised for acute myocardial infarction: an Australian cohort study 2018-2022.

Autor: Deakin CT; Medicines Intelligence Centre of Research Excellence, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia., Costa JO; Medicines Intelligence Centre of Research Excellence, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia., Brieger D; Department of Cardiology, Concord Repatriation General Hospital, Sydney, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Lin J; Medicines Intelligence Centre of Research Excellence, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia., Schaffer AL; Nuffield Department of Primary Care Health Sciences, Bennett Institute for Applied Data Science, University of Oxford, Oxford, UK., Kidd M; Centre for Future Health Systems, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia., Pearson SA; Medicines Intelligence Centre of Research Excellence, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia., Falster MO; Medicines Intelligence Centre of Research Excellence, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.

Publikováno v: European heart journal. Quality of care & clinical outcomes [Eur Heart J Qual Care Clin Outcomes] 2024 Aug 08. Date of Electronic Publication: 2024 Aug 08.

Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset.

Autor: Ciciriello S; OPAL Rheumatology Ltd., Sydney, NSW, Australia.; Royal Melbourne Hospital, Melbourne, VIC, Australia., Littlejohn G; OPAL Rheumatology Ltd., Sydney, NSW, Australia.; Department of Medicine, Monash University, VIC, Clayton, Australia., O'Sullivan C; OPAL Rheumatology Ltd., Sydney, NSW, Australia. cath.osullivan@opalrheumatology.com.au., Smith T; OPAL Rheumatology Ltd., Sydney, NSW, Australia., Deakin CT; OPAL Rheumatology Ltd., Sydney, NSW, Australia.; Centre for Adolescent Rheumatology Versus Arthritis at University College London, University College London Hospitals and Great Ormond Street Hospital, London, UK.; National Institute of Health Research Biomedical Centre at Great Ormond Street Hospital, London, UK.

Publikováno v: Clinical rheumatology [Clin Rheumatol] 2023 Nov; Vol. 42 (11), pp. 2971-2980. Date of Electronic Publication: 2023 Jul 05.

Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set.

Autor: Ciciriello S; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, and The Royal Melbourne Hospital Melbourne, Victoria, Australia., Littlejohn G; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, and Monash University, Clayton, Victoria, Australia., Treuer T; Eli Lilly and Company, Indianapolis, Indiana., Gibson KA; Eli Lilly and Company, Indianapolis, Indiana, Liverpool Hospital, Liverpool, New South Wales, Australia, and University of New South Wales, Kensington, New South Wales, Australia., Haladyj E; Eli Lilly and Company, Indianapolis, Indiana., Youssef P; OPAL Rheumatology Ltd, Royal Prince Albert Hospital, and University of Sydney, Sydney, New South Wales, Australia., Bird P; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, and University of New South Wales, Kensington, New South Wales, Australia., O'Sullivan C; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia., Smith T; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia., Deakin CT; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia, Centre for Adolescent Rheumatology Versus Arthritis at University College London, University College London Hospitals, Great Ormond Street Hospital and University College London, and National Institute of Health Research Biomedical Centre at Great Ormond Street Hospital, London, UK.

Publikováno v: ACR open rheumatology [ACR Open Rheumatol] 2023 Jul; Vol. 5 (7), pp. 345-353. Date of Electronic Publication: 2023 Jun 12.

Role of CD14+ monocyte-derived oxidised mitochondrial DNA in the inflammatory interferon type 1 signature in juvenile dermatomyositis.

Autor: Wilkinson MGL; Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK meredyth.wilkinson.14@ucl.ac.uk e.rosser@ucl.ac.uk.; Centre for Adolescent Rheumatology Versus Arthritis at UCL UCLH and GOSH, UCL, London, UK.; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK., Moulding D; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK.; Developmental Biology and Cancer Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK., McDonnell TCR; Centre for Rheumatology Research, Division of Medicine, University College London, London, UK., Orford M; Developmental Biology and Cancer Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK., Wincup C; Centre for Rheumatology Research, Division of Medicine, University College London, London, UK., Ting JYJ; Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK., Otto GW; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK.; Experimental and Personalised Medicine, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.; Genetics and Genomic Medicine Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK., Restuadi R; Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.; Centre for Adolescent Rheumatology Versus Arthritis at UCL UCLH and GOSH, UCL, London, UK.; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK., Kelberman D; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK.; Experimental and Personalised Medicine, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK.; Genetics and Genomic Medicine Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK., Papadopoulou C; Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.; Rheumatology, Great Ormond Street Hospital NHS Trust, London, UK., Castellano S; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK.; Genetics and Genomic Medicine Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK., Eaton S; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK.; Developmental Biology and Cancer Research & Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK., Deakin CT; Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.; Centre for Adolescent Rheumatology Versus Arthritis at UCL UCLH and GOSH, UCL, London, UK.; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK., Rosser EC; Centre for Adolescent Rheumatology Versus Arthritis at UCL UCLH and GOSH, UCL, London, UK meredyth.wilkinson.14@ucl.ac.uk e.rosser@ucl.ac.uk.; Centre for Rheumatology Research, Division of Medicine, University College London, London, UK., Wedderburn LR; Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.; Centre for Adolescent Rheumatology Versus Arthritis at UCL UCLH and GOSH, UCL, London, UK.; NIHR Biomedical Research Centre, Great Ormond Street Hospital, London, UK.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2023 May; Vol. 82 (5), pp. 658-669. Date of Electronic Publication: 2022 Dec 23.

Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA) - a drug-survival single centre study spanning 10 years.

Autor: Shipa MR; Centre for Rheumatology, Division of Medicine, University College London, London, UK. Rayne Institute, 5 University St, Bloomsbury, London WC1E 6JF UK., Heyer N; University College London Hospital, Department of adolescent and young adult Rheumatology, 250 Euston Road, London NW1 2PG UK., Mansoor R; Department of Population Health Sciences, King's College London Great Maze Pond, London SE1 9RT, UK., Deakin CT; Centre for Adolescent Rheumatology Versus Arthritis, Division of Medicine, University College London, London, UK. Rayne Institute, 5 University St, Bloomsbury, London WC1E 6JF UK; NIHR Biomedical Research Centre at Great Ormond Street Hospital, London, UK., Madenidou AV; Centre for Adolescent Rheumatology Versus Arthritis, Division of Medicine, University College London, London, UK. Rayne Institute, 5 University St, Bloomsbury, London WC1E 6JF UK., Bouraioui A; University College London Hospital, Department of adolescent and young adult Rheumatology, 250 Euston Road, London NW1 2PG UK., Fisher C; University College London Hospital, Department of adolescent and young adult Rheumatology, 250 Euston Road, London NW1 2PG UK; Biomedical Research Centre UCLH UK., Leandro M; Centre for Rheumatology, Division of Medicine, University College London, London, UK. Rayne Institute, 5 University St, Bloomsbury, London WC1E 6JF UK; University College London Hospital, Department of adolescent and young adult Rheumatology, 250 Euston Road, London NW1 2PG UK., Ciurtin C; University College London Hospital, Department of adolescent and young adult Rheumatology, 250 Euston Road, London NW1 2PG UK; Centre for Adolescent Rheumatology Versus Arthritis, Division of Medicine, University College London, London, UK. Rayne Institute, 5 University St, Bloomsbury, London WC1E 6JF UK., Sen D; University College London Hospital, Department of adolescent and young adult Rheumatology, 250 Euston Road, London NW1 2PG UK; Centre for Adolescent Rheumatology Versus Arthritis, Division of Medicine, University College London, London, UK. Rayne Institute, 5 University St, Bloomsbury, London WC1E 6JF UK; Biomedical Research Centre UCLH UK. Electronic address: d.sen@nhs.net.

Publikováno v: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2022 Aug; Vol. 55, pp. 152038. Date of Electronic Publication: 2022 May 28.